Barbara Harlin Bispham
CIK: 0002075230
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRESCENT BIOPHARMA, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
Sale(S)Direct620 shares at avg. $17.90$11K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
Sale(S)Direct1.2K shares at avg. $17.99$22K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
Award(A)Direct12.4K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
Award(A)Direct6K shares-
1-4 of 4 transactions
About Bispham Barbara Harlin
Bispham Barbara Harlin (SEC CIK 0002075230) files insider reports with the SEC as Officer of CRESCENT BIOPHARMA, INC. (CBIO).
Signal8 holds 4 ownership filings by Bispham Barbara Harlin (1 Form 3, 3 Form 4), filed between Jun 30, 2025 and Sep 18, 2026. Those filings report 4 transactions, from Dec 15, 2025 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bispham Barbara Harlin's filings is in WALTHAM, MA.
Recent filings by Bispham Barbara Harlin
Other insiders filing for CRESCENT BIOPHARMA, INC. (CBIO)
- Lynch Ryan
- Pinkas Jan, Chief Scientific Officer
- Im Ellie Eunkyung, Chief Medical Officer
- Scalzo Richard William, Chief Financial Officer
- Brumm Joshua T, Chief Executive Officer
- McNeill Jonathan, President and COO